Nutritional composition and bioactive compounds of mini watermelon genotypes in Bangladesh

Hasina Sultana; Sharmila Rani Mallick; Jahidul Hassan; Joydeb Gomasta; Md. Humayun Kabir; Md. Sakibul Alam Sakib; Mahmuda Hossen; Muhammad Mustakim Billah; Emrul Kayesh

arXiv · 2309.13565

Nutritional composition and bioactive compounds of mini watermelon genotypes in Bangladesh

Hasina Sultana·Sharmila Rani Mallick·Jahidul Hassan·Joydeb Gomasta·Md. Humayun Kabir·Md. Sakibul Alam Sakib·Mahmuda Hossen·Muhammad Mustakim Billah·Emrul Kayesh

View original source ↗Read source document ↗Export metadata ↓

Abstract

Given the present rising trends in changing lifestyle and consumption patterns, watermelon production has shifted from big to small-sized fruits having desirable quality attributes. Hence, analyses of fruit quality traits of mini watermelon are crucial to develop improved cultivars with enhanced nutritional compositions, consumer-preferred traits and extended storage life. In this context, fruit morphological and nutritional attributes of five mini watermelon genotypes namely BARI watermelon 1 (W1), BARI watermelon 2 (W2), L-32468 (W3), L-32236 (W4) and L-32394 (W5) were evaluated to appraise promising genotypes with better fruit quality. The evaluated genotypes expressed different levels of diversity for fruit physical qualitative traits including differences in shape, rind and flesh color and texture. The study also revealed significant variability among the genotypes regarding all observed fruit morphological and nutritional aspects as well as bioactive compounds. Among the studied genotypes, W1 stood out with the highest TSS as well as rind vitamin C and total phenolic content accompanied by higher fruit weight and thick rind. On the other hand, W3 genotype was featured with higher amount of \b{eta} carotene, total phenolic and flavonoid content in its flesh along with rind enriched with \b{eta} carotene and minerals. However, comparatively higher amount of sugar and total flavonoid content was recorded in the rind of W5 genotype. Therefore, W1 and W3 could be exploited for table purpose and using in breeding program to develop mini watermelon cultivars with more attractive fruits in terms of quality acceptance and nutritional value in Bangladesh. Furthermore, rind of BARI watermelon 1 and L-32394 could be considered as the potential cheap source of bioactive compounds to be used for dietary and industrial purpose which would decrease the solid waste in the environment.

Explore related subjects

q-bio.OT

Keep this discovery

BibTeX RIS

Hasina Sultana, Sharmila Rani Mallick, Jahidul Hassan, Joydeb Gomasta, Md. Humayun Kabir, Md. Sakibul Alam Sakib, Mahmuda Hossen, Muhammad Mustakim Billah, Emrul Kayesh. 2023-09-24. Nutritional composition and bioactive compounds of mini watermelon genotypes in Bangladesh. https://arxiv.org/abs/2309.13565

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

MarkerScout: A Disease-Agnostic Machine Learning Framework for Biomarker Prediction from Multi-Scale Mechanistic Models

We demonstrate the framework on three infectious diseases derived from a companion mechanistic immune-simulation platform: SARS-CoV-2, Influenza A Virus, and Plasmodium falciparum. Each disease was evaluated across hospitalization and intensive care unit cohorts, yielding six cohorts in total. Best-pipeline cross-validated macro F1 ranged from 0.82 for IAV-HOSP to 0.99 for COV-ICU, and the framework produced tiered, direction-aware biomarker lists for each disease and phase. Interleukin-18 (IL-18) reached the strongest tier in both SARS-CoV-2 phases with consistent direction. When benchmarked against three separate, independently collected clinical ICU datasets, MarkerScout's top-ranked features outperformed 94.4% of randomly selected feature sets of equivalent size for SARS-CoV-2, with a weaker but directionally consistent advantage for Influenza A Virus (66.7%) and Plasmodium falciparum (60.7%).

q-bio.OT↗

arXiv2026

Enhancing Clinical Decision Support and Differential Diagnosis with Knowledge Graphs, and Retrieval Augmented Generation in Generative AI

Diagnostic error carries a burden, while unconstrained large language models (LLMs) remain vulnerable to hallucination and weak integration of quantitative laboratory dynamics. We developed a decision-support pipeline combining disease-specific biomarker correlation graphs, ordinary differential equations (ODEs), deep sequence classification, and retrieval-augmented generation (RAG). For 103 disease classes from a full blood count (FBC) repository, biomarker networks were used as coupling matrices to generate 30 trajectories per disease (3,090 total). A one-dimensional convolutional neural network (CNN) and long short-term memory (LSTM) network classified disease trajectories and six dynamical clusters. A constrained GPT-4o-mini RAG layer used a 19-pattern BMJ Best Practice/NICE corpus to generate differential diagnoses evaluated for diagnostic suitability, evidential grounding, and clinical plausibility. Across five random-seed runs, disease-level accuracy was $0.940 \pm 0.006$ for the CNN (95\% CI 0.933--0.948) and $0.852 \pm 0.019$ for the LSTM (95\% CI 0.828--0.875); the CNN advantage was 8.87 percentage points (95\% CI 6.47--11.27; $t(4)=10.26$, $p=5.1\times10^{-4}$; Hedges' $g=3.67$). Among 100 sampled RAG cases, 96 parsed successfully; evidence was cited in 97.9\%, the true diagnosis was mentioned in 71.9\%, and the composite score was 3.82/5 with a 47.9\% strict pass rate. The central finding was a decoupling between grounding and diagnostic correctness: classifier-correct versus classifier-wrong outputs differed in diagnostic suitability but not evidential grounding. Post-hoc analysis confirmed a 1.02-point diagnostic-score difference (Mann--Whitney $p=0.0024$; Hedges' $g=0.72$), whereas grounding differed by only $-0.02$ points ($p=0.839$; $g=-0.04$).

q-bio.OT↗

arXiv2026

Expanding the Human Ancestry Ontology to include under-represented populations and ethnicities for broader utility in annotations

Successful discovery, integration and reuse of data relies on the availability of rich, well-structured and machine-readable metadata to describe every aspect of the data, from sample sources to collection processes to experimental protocols. The use of standardised terminologies to express concepts in a harmonised fashion lies at the core of high-quality data annotation, increasing the FAIRness of the data, facilitating data integration and promoting reproducibility. Here, we describe the Human Ancestry Ontology (HANCESTRO), originally developed to improve standardised reporting of genetic ancestry genomic resources such as the NHGRI-EBI GWAS Catalog and the Human Cell Atlas through high-level population descriptors, and more recently expanded to include diverse and previously under-represented populations in genomics and genetics research. HANCESTRO provides a framework for population descriptors that includes both ancestry based on the analysis of genetic information and self-reported ethnicity, which is based on social and cultural factors that don't necessarily align with genetic populations. By enabling the accurate and interoperable representation of population-related data, it promotes inclusive, representative and reproducible science.

q-bio.OT↗